Oral administration of sophoricoside (SOP) inhibits neuronal damage and neuroinflammation to curb neurodegeneration in Parkinson's disease.
Chem Biol Interact
; 384: 110726, 2023 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-37741537
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Neuroprotective Agents
Limits:
Animals
Language:
En
Journal:
Chem Biol Interact
Year:
2023
Document type:
Article
Country of publication:
Ireland